Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > RE: Paladin, psoriasis, et al.> pathetic ISA
View:
Post by ISAloser247 on Jun 04, 2012 11:24am

RE: Paladin, psoriasis, et al.> pathetic ISA

..Paladin includes withdrawal statement in annual report:  ISA management ( mutton, platinum bomb ), considering it was a joint submission,  were clueless at AGM 2011.  Something 'mutt'ered about 'ball in Paladin's court" and 'I don't know" ...... probably the same responses forthcoming about Iljin termination, funny how there is ;absolutely NO MENTION of psoriasis withdrawal on ISA website!  TOP NOTCH MANAGEMENT! TOP NOTCH GUIDANCE!! THOSE JOINT VENTURES WITH OTHERS ARE JUST STREAMING IN THE DOOR!  SO MANY, SUCH GREAT OFFERS,  WHAT TO DO?  WHAT TO DO? THAT HOME SHOPPING CHANNEL APPEARANCE , BROUGHT TOO MUCH EXPOSURE!  TOO MANY INTERESTED PARTIES!
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities